Carisma Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Carisma Therapeutics (CARM) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Carisma Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Carisma Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Carisma Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $251 | 921 | 0.27 |
| 2025-03-31 | $294 | 948 | 0.31 |
| 2024-12-31 | $385 | 921 | 0.42 |
| 2024-09-30 | $903 | 921 | 0.98 |
| 2024-06-30 | $1.4k | 921 | 1.52 |
| 2024-03-31 | $27k | 12k | 2.27 |
| 2023-12-31 | $52k | 18k | 2.93 |
| 2023-09-30 | $74k | 18k | 4.23 |
| 2023-06-30 | $184k | 21k | 8.77 |
| 2023-03-31 | $999 | 291 | 3.44 |